<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Xanthogranulomatous cholecystitis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Xanthogranulomatous cholecystitis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Xanthogranulomatous cholecystitis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shyam Varadarajulu, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Salam F Zakko, MD, FACP, AGAF
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sanjiv Chopra, MD, MACP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shilpa Grover, MD, MPH, AGAF
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 13, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Xanthogranulomatous cholecystitis is a rare benign inflammatory disease of the gallbladder that may be misdiagnosed as carcinoma of the gallbladder on imaging [
         <a href="#rid1">
          1-4
         </a>
         ]. Xanthogranulomatous cholecystitis is characterized by a focal or diffuse destructive inflammatory process, with accumulation of lipid laden macrophages, fibrous tissue, and acute and chronic inflammatory cells.
        </p>
        <p>
         Xanthogranulomatous cholecystitis, previously known as fibro-xanthogranulomatous cholecystitis, was initially described as a variant of chronic cholecystitis. However, it is now recognized as a distinct clinical entity that can lead to significant morbidity as the inflammatory process usually extends into the gallbladder wall and adjacent structures. This topic will review the clinical features, diagnosis, and management of xanthogranulomatous cholecystitis. Other causes of acute cholecystitis are discussed in detail, separately. (See
         <a class="medical medical_review" href="/z/d/html/666.html" rel="external">
          "Acute calculous cholecystitis: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3684.html" rel="external">
          "Treatment of acute calculous cholecystitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/672.html" rel="external">
          "Acalculous cholecystitis: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevalence of xanthogranulomatous cholecystitis varies by geographic region. The pooled prevalence of xanthogranulomatous cholecystitis in epidemiologic studies of European, Americas, or Far Eastern cohorts ranges from 1.3 to 1.9 percent in Europe and the Americas and up to 9 percent in India [
         <a href="#rid5">
          5-10
         </a>
         ]. The mean age at presentation ranges from 44 to 63 years [
         <a href="#rid5">
          5,11
         </a>
         ]. While some studies have reported a male predominance, others have found no sex predilection [
         <a href="#rid3">
          3,5,8,11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis of xanthogranulomatous cholecystitis may be related to extravasation of bile into the gallbladder wall from rupture of Rokitansky-Aschoff sinuses or by mucosal ulceration [
         <a href="#rid3">
          3,12
         </a>
         ]. This event incites an inflammatory reaction in the interstitial tissue, whereby fibroblasts and macrophages phagocytose the biliary lipids in bile, such as cholesterol and phospholipids, leading to the formation of xanthoma cells.
        </p>
        <p>
         Gallstones are present in the majority of patients and may have an important role in the pathogenesis [
         <a href="#rid5">
          5,11,13
         </a>
         ]. It is hypothesized that xanthogranulomatous cholecystitis is analogous to xanthogranulomatous pyelonephritis, which results from obstruction and stasis due to renal calculi [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8058.html" rel="external">
          "Xanthogranulomatous pyelonephritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H3710745476">
         <span class="h2">
          Presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Presenting symptoms in patients with xanthogranulomatous cholecystitis include acute onset of right upper quadrant abdominal pain (85 percent), nausea (26 percent), and vomiting (22 percent). On physical examination, a positive Murphy's sign is present in approximately 53 percent of patients, and can mimic acute cholecystitis. (See
         <a class="medical medical_review" href="/z/d/html/666.html" rel="external">
          "Acute calculous cholecystitis: Clinical features and diagnosis", section on 'Clinical manifestations'
         </a>
         and
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         Other patients may have more chronic symptoms, including weight loss (9 percent) and anorexia (18 percent) [
         <a href="#rid10">
          10
         </a>
         ]. A right hypochondrial mass is palpable in approximately 10 percent of patients, mimicking carcinoma of the gallbladder [
         <a href="#rid15">
          15-17
         </a>
         ]. Approximately 20 percent of patients have jaundice at presentation due to obstructive complications of xanthogranulomatous cholecystitis [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="local">
          'Complications'
         </a>
         below and
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4167337670">
         <span class="h2">
          Imaging findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging may be suggestive of xanthogranulomatous cholecystitis but is not specific.
        </p>
        <p class="headingAnchor" id="H736357301">
         <span class="h3">
          Ultrasonography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Features of xanthogranulomatous cholecystitis include hypoechoic nodules or bands in the gallbladder wall and a diffusely thickened gallbladder [
         <a href="#rid15">
          15,18,19
         </a>
         ]. Other findings on ultrasonography include a gallbladder mass, subhepatic fluid collection, obscure border between the gallbladder and liver, and rarely, gas in the biliary tree in patients with a biliary fistula [
         <a href="#rid15">
          15
         </a>
         ]. Concurrent gallstones are frequently present. Contrast-enhanced ultrasound may be more sensitive as compared with transabdominal ultrasound [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         However, findings on ultrasonography are not specific for xanthogranulomatous cholecystitis. Intramural hypoechoic nodules can be seen in other conditions, including intramural abscesses, cholesterolosis, and adenomyomatosis [
         <a href="#rid21">
          21-23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/646.html" rel="external">
          "Gallbladder polyps"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2577622728">
         <span class="h3">
          Computed tomography (CT) and magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Features of xanthogranulomatous cholecystitis on CT and MRI include diffuse gallbladder wall thickening, intramural nodules, and a smooth gallbladder wall  (
         <a class="graphic graphic_diagnosticimage graphicRef54177" href="/z/d/graphic/54177.html" rel="external">
          image 1
         </a>
         ). After contrast enhancement features of xanthogranulomatous cholecystitis include continuous enhancement of the mucosal line, pericholecystic infiltration, transient hepatic attenuation difference at the gallbladder bed of the liver, and luminal surface enhancement [
         <a href="#rid7">
          7,19,24,25
         </a>
         ].
        </p>
        <p>
         CT and magnetic resonance findings in xanthogranulomatous cholecystitis correlate with pathologic findings [
         <a href="#rid26">
          26
         </a>
         ]. Low-attenuation areas in the wall of the gallbladder correlate with foam and inflammatory cells or necrosis and/or abscess in xanthogranulomatous cholecystitis. Areas of iso- to slightly high signal intensity on T2-weighted images, showing slight enhancement at early phase and strong enhancement at last phase on dynamic study, correspond with areas of abundant xanthogranulomas. Areas with very high signal intensity on T2-weighted images without enhancement correspond with necrosis and/or abscesses.
        </p>
        <p>
         However, imaging features of xanthogranulomatous cholecystitis and carcinoma of the gallbladder are similar, and both conditions can co-exist [
         <a href="#rid24">
          24
         </a>
         ]. In a retrospective study that compared the CT features of 18 patients with xanthogranulomatous cholecystitis and 17 patients with gallbladder cancer, the following imaging features were useful in diagnosing xanthogranulomatous cholecystitis:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diffuse gallbladder wall thickening: sensitivity 89 percent, specificity 65 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Continuous mucosal line: sensitivity 67 percent, specificity 82 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intramural hypoattenuated nodules: sensitivity 61 percent, specificity 71 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Absence of macroscopic hepatic invasion: sensitivity 72 percent, specificity 77 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Absence of intrahepatic bile duct dilatation: sensitivity 67 percent, specificity 71 percent
        </p>
        <p>
        </p>
        <p>
         When at least three of these five CT findings were observed, the sensitivity, specificity, and accuracy were 83, 100, and 91 percent, respectively. However, these results have not been validated and these features are not uniformly reported in clinical practice.
        </p>
        <p>
         MRI may have higher accuracy as compared with CT and ultrasound in differentiating between xanthogranulomatous cholecystitis and carcinoma of the gallbladder, and MRCP has the advantage of delineating abnormal dilated ducts and can evaluate the level of obstruction.
        </p>
        <p class="headingAnchor" id="H2471626175">
         <span class="h2">
          Laboratory findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory studies are usually normal, but approximately 20 percent of patients have obstructive jaundice with elevated liver enzymes in a primarily cholestatic pattern (disproportionate elevation of the alkaline phosphatase, gamma-glutamyl transferase, and bilirubin) [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2318686257">
         <span class="h2">
          Complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 30 percent of patients with xanthogranulomatous cholecystitis have complications at presentation [
         <a href="#rid15">
          15
         </a>
         ]. Local complications include gallbladder perforation and bile duct obstruction. Bile duct obstruction may be due to development of strictures of the bile duct (xanthogranulomatous choledochitis) or choledocholithiasis, and rarely, is due to extrinsic compression of the bile duct (Mirizzi syndrome) [
         <a href="#rid9">
          9
         </a>
         ]. Prolonged cystic duct obstruction and gallbladder distension under pressure during the acute inflammatory phase can lead to extension of the xanthogranulomatous inflammation beyond the gallbladder with formation of hepatic abscesses and fistulas into adjacent structures, such as the liver, duodenum, stomach, colon, and skin [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/656.html" rel="external">
          "Mirizzi syndrome"
         </a>
         .)
        </p>
        <p>
         It is unclear if there is any association between gallbladder cancer and xanthogranulomatous cholecystitis. In rare cases, gallbladder carcinoma may be present concurrently [
         <a href="#rid11">
          11,27
         </a>
         ]. In a larger series of 460 cholecystectomies performed for various gallbladder diseases, xanthogranuloma and carcinoma of the gallbladder were noted in only one case (0.2 percent) [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3247987823">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Xanthogranulomatous cholecystitis may be confused for gallbladder cancer in its clinical presentation and radiographic appearance [
         <a href="#rid28">
          28,29
         </a>
         ]. Histopathological evaluation of the gallbladder usually facilitates differentiation of these disorders, although rarely the two can occur together. The clinical presentation of xanthogranulomatous cholecystitis can be similar to that of acute cholecystitis, however, the imaging findings are distinct. (See
         <a class="medical medical_review" href="/z/d/html/666.html" rel="external">
          "Acute calculous cholecystitis: Clinical features and diagnosis", section on 'Diagnostic imaging'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          DIAGNOSTIC EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H208619402">
         <span class="h2">
          Clinical suspicion and diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of xanthogranulomatous cholecystitis is often made incidentally on histological examination of the resected gallbladder in a patient with suspected acute cholecystitis. However, a diagnosis of xanthogranulomatous cholecystitis should also be considered in the following clinical scenarios:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Right upper quadrant mass and/or pneumobilia suggestive of an enterobiliary fistula on abdominal imaging. In such cases, we perform a magnetic resonance imaging/magnetic resonance cholangiopancreatography to delineate the biliary tree prior to surgery. (See
         <a class="local">
          'Imaging findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients undergoing cholecystectomy, a markedly thick-walled gallbladder with extensive, dense, fibrous adhesions to neighboring structures should raise the suspicion for xanthogranulomatous cholecystitis. Intraoperative findings cannot reliably differentiate between gallbladder cancer and xanthogranulomatous cholecystitis. The presence of enlarged lymph nodes and the loss of interface between the gallbladder and liver bed intra-operatively can be seen in both xanthogranulomatous cholecystitis and gallbladder cancer. Intraoperative frozen section analysis should be performed to diagnose gallbladder cancer as this impacts surgical decision-making [
         <a href="#rid11">
          11,30
         </a>
         ]. In a study of 142 patients with xanthogranulomatous cholecystitis, 42 were misdiagnosed as gallbladder cancer based on preoperative radiographs and/or intraoperative findings [
         <a href="#rid31">
          31
         </a>
         ]. The accuracy rate of frozen section analysis and that of the surgeon's macroscopic diagnosis were 93 and 50 percent, respectively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We do not perform fine needle aspiration cytology either pre-operatively or intra-operatively in patients with suspected xanthogranulomatous cholecystitis. Fine needle aspiration cytology can diagnose xanthogranulomatous cholecystitis [
         <a href="#rid16">
          16,31-33
         </a>
         ]. However, cytology may be falsely negative for a concurrent gallbladder cancer and the procedure can create a fistula and can lead to seeding of the track with tumour. (See
         <a class="medical medical_review" href="/z/d/html/2656.html" rel="external">
          "Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1447033532">
         <span class="h2">
          Surgical pathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         On gross examination, the gallbladder is thickened and the serosa is covered with dense fibrous adhesions  (
         <a class="graphic graphic_picture graphicRef67995" href="/z/d/graphic/67995.html" rel="external">
          picture 1
         </a>
         ). The mucosal surface may be ulcerated and cross sections through the wall reveal xanthogranulomatous foci, which appear as yellow nodules or plaques. These yellowish foci may extend into adjacent structures, such as the liver, duodenum, transverse colon, and omentum [
         <a href="#rid5">
          5,11
         </a>
         ].
        </p>
        <p>
         Microscopically, the xanthogranulomatous foci are composed of abundant lipid laden macrophages, fibroblasts, and inflammatory cells  (
         <a class="graphic graphic_picture graphicRef75696" href="/z/d/graphic/75696.html" rel="external">
          picture 2
         </a>
         ). The lipid laden macrophages are of two morphological types: rounded foamy macrophages and spindle-shaped cells with more granular cytoplasm and elongated nuclei. Other findings include the presence of cholesterol clefts, lipid droplets, hemosiderin deposits, and extravasated bile [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The only definitive treatment for xanthogranulomatous cholecystitis is cholecystectomy. Due to the inflammatory and invasive nature of xanthogranulomatous cholecystitis, complete resection of the xanthogranulomatous tissue adjacent to the gallbladder should be attempted, even if this includes resection into the hepatic bed [
         <a href="#rid15">
          15,34
         </a>
         ]. An intraoperative frozen section should be performed to exclude gallbladder cancer [
         <a href="#rid11">
          11,30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3684.html" rel="external">
          "Treatment of acute calculous cholecystitis", section on 'Surgical approach'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15097.html" rel="external">
          "Surgical management of gallbladder cancer", section on 'Resection techniques'
         </a>
         .)
        </p>
        <p>
         In most patients requiring surgery for xanthogranulomatous cholecystitis, open cholecystectomy is required due to dense fibrosis and extensive local inflammation [
         <a href="#rid35">
          35,36
         </a>
         ]. Laparoscopic cholecystectomy may be attempted, but conversion to open surgery is often required. The conversion rate ranged from 16 to 80 percent in reported case series [
         <a href="#rid8">
          8,35-38
         </a>
         ]. Given the clinical presentation of biliary obstruction, patients frequently require preoperative biliary drainage via endoscopic or percutaneous methods [
         <a href="#rid38">
          38
         </a>
         ]. Higher complication rates (including bile duct injury) have also been reported with laparoscopic cholecystectomy for xanthogranulomatous cholecystitis [
         <a href="#rid37">
          37
         </a>
         ]. When the hepatocystic triangle has been obscured by the inflammatory process, subtotal cholecystectomy is an option to avoid major complications, as long as gallbladder cancer has been excluded by intraoperative frozen section [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/109437.html" rel="external">
          "Managing the difficult gallbladder", section on 'Subtotal cholecystectomy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Morbidity following resection of xanthogranulomatous cholecystitis is largely related to postoperative complications. The postoperative morbidity rates were 30 and 32 percent in two series and were mainly related to wound infections, particularly in patients with fistulae [
         <a href="#rid11">
          11,15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2555342513">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115384.html" rel="external">
          "Society guideline links: Cholecystitis and other gallbladder disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Xanthogranulomatous cholecystitis is a rare inflammatory disease of the gallbladder characterized by a focal or diffuse destructive inflammatory process, with accumulation of lipid laden macrophages, fibrous tissue, and acute and chronic inflammatory cells. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The mean age at presentation ranges from 44 to 63 years. Presenting symptoms in patients with xanthogranulomatous cholecystitis include acute onset of right upper quadrant abdominal pain, nausea, and vomiting. On physical examination, a positive Murphy's sign may be present and can mimic acute cholecystitis. Other patients may have more chronic symptoms, including weight loss and anorexia. A right hypochondrial mass is palpable in approximately 10 percent of patients, mimicking carcinoma of the gallbladder. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Features of xanthogranulomatous cholecystitis on abdominal imaging include hypoechoic nodules or bands in the gallbladder wall and a diffusely thickened gallbladder. However, imaging features of xanthogranulomatous cholecystitis are not specific. In addition, imaging cannot reliably distinguish between xanthogranulomatous cholecystitis and carcinoma of the gallbladder, and both conditions can co-exist. (See
         <a class="local">
          'Imaging findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Approximately 30 percent of patients with xanthogranulomatous cholecystitis have complications at presentation. Local complications include gallbladder perforation and bile duct obstruction. Prolonged cystic duct obstruction and gallbladder distension under pressure during the acute inflammatory phase can lead to extension of the xanthogranulomatous inflammation beyond the gallbladder with formation of hepatic abscesses and fistulas into adjacent structures, such as the liver, duodenum, stomach, colon, and skin. (See
         <a class="local">
          'Complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of xanthogranulomatous cholecystitis is often made incidentally on histological examination of the resected gallbladder in a patient with suspected acute cholecystitis. However, a diagnosis of xanthogranulomatous cholecystitis should also be considered in patients with right upper quadrant mass and/or pneumobilia suggestive of a enterobiliary fistula. In patients undergoing cholecystectomy, a markedly thick-walled gallbladder with extensive, dense, fibrous adhesions to neighboring structures should raise the suspicion for xanthogranulomatous cholecystitis. (See
         <a class="local">
          'Diagnostic evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients in whom xanthogranulomatous cholecystitis is suspected pre-operatively, we perform an magnetic resonance cholangiopancreatography to delineate the biliary tree prior to surgery. Patients presenting with symptomatic biliary obstruction such as cholangitis may require preoperative biliary ductal decompression. The only definitive treatment for xanthogranulomatous cholecystitis is cholecystectomy. Intraoperative frozen section analysis should be performed to diagnose or exclude gallbladder cancer. A complete resection of adjacent xanthogranulomatous tissue should be attempted, even if this includes resection into the hepatic bed. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Jessurun J, Albores-Saavedra J. Gallbladder and Extrahepatic Biliary Ducts. In: Anderson's Pathology, Damjanov I, Linder J (Eds), CV Mosby, St. Louis 1996. p.1859.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol 1970; 90:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodman ZD, Ishak KG. Xanthogranulomatous cholecystitis. Am J Surg Pathol 1981; 5:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Z, Dong H, Zhang L, et al. Xanthogranulomatous Cholecystitis Masquerading as Gallbladder Carcinoma on 68 Ga-FAPI-04 PET. Clin Nucl Med 2022; 47:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixit VK, Prakash A, Gupta A, et al. Xanthogranulomatous cholecystitis. Dig Dis Sci 1998; 43:940.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reyes CV, Jablokow VR, Reid R. Xanthogranulomatous cholecystitis: report of seven cases. Am Surg 1981; 47:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanada K, Nakata H, Nakayama T, et al. Radiologic findings in xanthogranulomatous cholecystitis. AJR Am J Roentgenol 1987; 148:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guzmán-Valdivia G. Xanthogranulomatous cholecystitis: 15 years' experience. World J Surg 2004; 28:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krishna RP, Kumar A, Singh RK, et al. Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation and surgical management. J Gastrointest Surg 2008; 12:836.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hale MD, Roberts KJ, Hodson J, et al. Xanthogranulomatous cholecystitis: a European and global perspective. HPB (Oxford) 2014; 16:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts KM, Parsons MA. Xanthogranulomatous cholecystitis: clinicopathological study of 13 cases. J Clin Pathol 1987; 40:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takahashi K, Oka K, Hakozaki H, Kojima M. Ceroid-like histiocytic granuloma of gall-bladder --a previously undescribed lesion--. Acta Pathol Jpn 1976; 26:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshida J, Chijiiwa K, Shimura H, et al. Xanthogranulomatous cholecystitis versus gallbladder cancer: clinical differentiating factors. Am Surg 1997; 63:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fligiel S, Lewin KJ. Xanthogranulomatous cholecystitis: case report and review of the literature. Arch Pathol Lab Med 1982; 106:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Houston JP, Collins MC, Cameron I, et al. Xanthogranulomatous cholecystitis. Br J Surg 1994; 81:1030.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rao RV, Kumar A, Sikora SS, et al. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma. Trop Gastroenterol 2005; 26:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Düber C, Störkel S, Wagner PK, Müller J. Xanthogranulomatous cholecystitis mimicking carcinoma of the gallbladder: CT findings. J Comput Assist Tomogr 1984; 8:1195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim PN, Ha HK, Kim YH, et al. US findings of xanthogranulomatous cholecystitis. Clin Radiol 1998; 53:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parra JA, Acinas O, Bueno J, et al. Xanthogranulomatous cholecystitis: clinical, sonographic, and CT findings in 26 patients. AJR Am J Roentgenol 2000; 174:979.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuan HX, Wang WP, Wen JX, et al. Xanthogranulomatous cholecystitis: contrast-enhanced ultrasound features and differential diagnosis from wall-thickening gallbladder carcinoma. Discov Med 2016; 21:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graif M, Horovitz A, Itzchak Y, Strauss S. Hyperechoic foci in the gallbladder wall as a sign of microabscess formation or diverticula. Radiology 1984; 152:781.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghavendra BN, Subramanyam BR, Balthazar EJ, et al. Sonography of adenomyomatosis of the gallbladder: radiologic-pathologic correlation. Radiology 1983; 146:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jutras JA. Hyperplastic cholecystoses; Hickey lecture, 1960. Am J Roentgenol Radium Ther Nucl Med 1960; 83:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chun KA, Ha HK, Yu ES, et al. Xanthogranulomatous cholecystitis: CT features with emphasis on differentiation from gallbladder carcinoma. Radiology 1997; 203:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang TW, Kim SH, Park HJ, et al. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI. Clin Radiol 2013; 68:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shuto R, Kiyosue H, Komatsu E, et al. CT and MR imaging findings of xanthogranulomatous cholecystitis: correlation with pathologic findings. Eur Radiol 2004; 14:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lopez JI, Elizalde JM, Calvo MA. Xanthogranulomatous cholecystitis associated with gallbladder adenocarcinoma. A clinicopathological study of 5 cases. Tumori 1991; 77:358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kishore R, Nundy S, Mehrotra S, et al. Strategies for Differentiating Gallbladder Carcinoma from Xanthogranulomatous Cholecystitis-a Tertiary Care Centre Experience. Indian J Surg Oncol 2017; 8:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srinivas GN, Sinha S, Ryley N, Houghton PW. Perfidious gallbladders - a diagnostic dilemma with xanthogranulomatous cholecystitis. Ann R Coll Surg Engl 2007; 89:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hales MS, Miller TR. Diagnosis of xanthogranulomatous cholecystitis by fine needle aspiration biopsy. A case report. Acta Cytol 1987; 31:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deng YL, Cheng NS, Zhang SJ, et al. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases. World J Gastroenterol 2015; 21:12653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shukla S, Krishnani N, Jain M, et al. Xanthogranulomatous cholecystitis. Fine needle aspiration cytology in 17 cases. Acta Cytol 1997; 41:413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal AK, Kalayarasan R, Javed A, Sakhuja P. Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer. J Gastrointest Surg 2013; 17:1257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reed A, Ryan C, Schwartz SI. Xanthogranulomatous cholecystitis. J Am Coll Surg 1994; 179:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwon AH, Matsui Y, Uemura Y. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis. J Am Coll Surg 2004; 199:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guzmán-Valdivia G. Xanthogranulomatous cholecystitis in laparoscopic surgery. J Gastrointest Surg 2005; 9:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JW, Kim KH, Kim SJ, Lee SK. Xanthogranulomatous cholecystitis: Is an initial laparoscopic approach feasible? Surg Endosc 2017; 31:5289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makimoto S, Takami T, Hatano K, et al. Xanthogranulomatous cholecystitis: a review of 31 patients. Surg Endosc 2021; 35:3874.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yucel O, Uzun MA, Tilki M, et al. Xanthogranulomatous Cholecystitis: Analysis of 108 Patients. Indian J Surg 2017; 79:510.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 635 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Jessurun J, Albores-Saavedra J. Gallbladder and Extrahepatic Biliary Ducts. In: Anderson's Pathology, Damjanov I, Linder J (Eds), CV Mosby, St. Louis 1996. p.1859.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4319984" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Benign tumors and pseudotumors of the gallbladder. Report of 180 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7337158" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35485853" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Xanthogranulomatous Cholecystitis Masquerading as Gallbladder Carcinoma on 68 Ga-FAPI-04 PET.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9590403" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7258841" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Xanthogranulomatous cholecystitis: report of seven cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3548285" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Radiologic findings in xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14961199" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Xanthogranulomatous cholecystitis: 15 years' experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18266047" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation and surgical management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23991684" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Xanthogranulomatous cholecystitis: a European and global perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3584484" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Xanthogranulomatous cholecystitis: clinicopathological study of 13 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/179273" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Ceroid-like histiocytic granuloma of gall-bladder --a previously undescribed lesion--.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9124762" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Xanthogranulomatous cholecystitis versus gallbladder cancer: clinical differentiating factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6896437" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Xanthogranulomatous cholecystitis: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7922056" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15974235" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6501633" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Xanthogranulomatous cholecystitis mimicking carcinoma of the gallbladder: CT findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9585046" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : US findings of xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10749233" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Xanthogranulomatous cholecystitis: clinical, sonographic, and CT findings in 26 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27011044" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Xanthogranulomatous cholecystitis: contrast-enhanced ultrasound features and differential diagnosis from wall-thickening gallbladder carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6431493" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Hyperechoic foci in the gallbladder wall as a sign of microabscess formation or diverticula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6402802" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Sonography of adenomyomatosis of the gallbladder: radiologic-pathologic correlation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14408274" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Hyperplastic cholecystoses; Hickey lecture, 1960.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9122422" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Xanthogranulomatous cholecystitis: CT features with emphasis on differentiation from gallbladder carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23622795" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12904879" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : CT and MR imaging findings of xanthogranulomatous cholecystitis: correlation with pathologic findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1746061" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Xanthogranulomatous cholecystitis associated with gallbladder adenocarcinoma. A clinicopathological study of 5 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29203989" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Strategies for Differentiating Gallbladder Carcinoma from Xanthogranulomatous Cholecystitis-a Tertiary Care Centre Experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17346415" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Perfidious gallbladders - a diagnostic dilemma with xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3604543" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Diagnosis of xanthogranulomatous cholecystitis by fine needle aspiration biopsy. A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26640342" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9100775" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Xanthogranulomatous cholecystitis. Fine needle aspiration cytology in 17 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23615807" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8044399" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15275874" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15797229" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Xanthogranulomatous cholecystitis in laparoscopic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28593410" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Xanthogranulomatous cholecystitis: Is an initial laparoscopic approach feasible?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32720174" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Xanthogranulomatous cholecystitis: a review of 31 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29217901" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Xanthogranulomatous Cholecystitis: Analysis of 108 Patients.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
